Regulation of adrenomedullin and its family peptide by RAMP system - Lessons from genetically engineered mice

Current Protein and Peptide Science

Volumn 14, Issue 5, 2013, Pages 347-357

  Shindo, Takayuki ^a   Sakurai, Takayuki ^a   Kamiyoshi, Akiko ^a   Ichikawa Shindo, Yuka ^a   Shimoyama, Natsumi ^a   Iinuma, Nobuyoshi ^a   Arai, Takuma ^a   Miyagawa, Shinichi ^a  

^a SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adrenomedullin; Angiogenesis; Endothelial cell; Knockout mouse; Lymphangiogenesis; Receptor activity modifying proteins

Indexed keywords

ADRENOMEDULLIN; ADRENOMEDULLIN RECEPTOR; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN RECEPTOR LIKE RECEPTOR; CD31 ANTIGEN; CYCLIC AMP DEPENDENT PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; RECEPTOR ACTIVITY MODIFYING PROTEIN; RECEPTOR ACTIVITY MODIFYING PROTEIN 1; RECEPTOR ACTIVITY MODIFYING PROTEIN 2; RECEPTOR ACTIVITY MODIFYING PROTEIN 3;

ANGIOGENESIS; ARTICLE; ATHEROSCLEROSIS; BLEEDING; BLOOD PRESSURE FLUCTUATION; EDEMA; ENDOTHELIUM CELL; GENE EXPRESSION; GENE MUTATION; GESTATION PERIOD; HEART FAILURE; HUMAN; KNOCKOUT MOUSE; LIMB ISCHEMIA; LIVER SINUSOID; LIVER TRANSPLANTATION; LYMPHANGIOGENESIS; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; RECEPTOR AFFINITY; SURVIVAL;

ADRENOMEDULLIN; ANIMALS; ANIMALS, GENETICALLY MODIFIED; CALCITONIN GENE-RELATED PEPTIDE; GENE REGULATORY NETWORKS; MICE; MICE, KNOCKOUT; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTOR ACTIVITY-MODIFYING PROTEINS;

EID: 84882580775     PISSN: 13892037     EISSN: 18755550     Source Type: Journal    
DOI: 10.2174/13892037113149990052     Document Type: Article

References (60)

1. Kitamura, K.; Kangawa, K.; Kawamoto, M.; Ichiki, Y.; Nakamura, S.; Matsuo, H.; Eto, T. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem. Biophys. Res. Commun., 1993, 192, 553-560.
2. Ichiki, Y.; Kitamura, K.; Kangawa, K.; Kawamoto, M.; Matsuo, H.; Eto, T. Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma. FEBS Lett., 1994, 338, 6-10.
3. Jougasaki, M.; Wei, C.M.; Aarhus, L.L.; Heublein, D.M.; Sandberg, S.M.; Burnett, J.C., Jr. Renal localization and actions of adrenomedullin: a natriuretic peptide. Am. J. Physiol., 1995, 268, F657-F663.
4. Nishikimi, T.; Matsuoka, H. Cardiac adrenomedullin: its role in cardiac hypertrophy and heart failure. Curr. Med. Chem. Cardiovasc. Hematol. Agents, 2005, 3, 231-242.
5. Samson, W.K.; Murphy, T.; Schell, D.A. A novel vasoactive peptide, adrenomedullin, inhibits pituitary adrenocorticotropin release. Endocrinology, 1995, 136, 2349-2352.
6. Petrie, M.C.; Hillier, C.; Morton, J.J.; McMurray, J.J. Adrenomedullin selectively inhibits angiotensin II-induced aldosterone secretion in humans. J. Hypertens., 2000, 18, 61-64.
7. Isumi, Y.; Kubo, A.; Katafuchi, T.; Kangawa, K.; Minamino, N. Adrenomedullin suppresses interleukin-1beta-induced tumor necrosis factor-alpha production in Swiss 3T3 cells. FEBS Lett., 1999, 463, 110-114.
8. Shimosawa, T.; Shibagaki, Y.; Ishibashi, K.; Kitamura, K.; Kangawa, K.; Kato, S.; Ando, K.; Fujita, T. Adrenomedullin, an endogenous peptide, counteracts cardiovascular damage. Circulation, 2002, 105, 106-111.
9. Shimosawa, T.; Ogihara, T.; Matsui, H.; Asano, T.; Ando, K.; Fujita, T. Deficiency of adrenomedullin induces insulin resistance by increasing oxidative stress. Hypertension, 2003, 41, 1080-1085.
10. Kano, H.; Kohno, M.; Yasunari, K.; Yokokawa, K.; Horio, T.; Ikeda, M.; Minami, M.; Hanehira, T.; Takeda, T.; Yoshikawa, J. Adrenomedullin as a novel antiproliferative factor of vascular smooth muscle cells. J. Hypertens., 1996, 14, 209-213.
11. Miyashita, K.; Itoh, H.; Sawada, N.; Fukunaga, Y.; Sone, M.; Yamahara, K.; Yurugi, T.; Nakao, K. Adrenomedullin promotes proliferation and migration of cultured endothelial cells. Hypertens Res, 2003, 26 Suppl, S93-S98.
12. Iwasaki, H.; Eguchi, S.; Shichiri, M.; Marumo, F.; Hirata, Y. Adrenomedullin as a novel growth-promoting factor for cultured vascular smooth muscle cells: role of tyrosine kinase-mediated mitogen-activated protein kinase activation. Endocrinology, 1998, 139, 3432-3441.
13. Kobayashi, K.; Kitamura, K.; Etoh, T.; Nagatomo, Y.; Takenaga, M.; Ishikawa, T.; Imamura, T.; Koiwaya, Y.; Eto, T. Increased plasma adrenomedullin levels in chronic congestive heart failure. Am. Heart J., 1996, 131, 994-998.
14. Ishimitsu, T.; Nishikimi, T.; Saito, Y.; Kitamura, K.; Eto, T.; Kangawa, K.; Matsuo, H.; Omae, T.; Matsuoka, H. Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure. J. Clin. Invest., 1994, 94, 2158-2161.
15. McLatchie, L.M.; Fraser, N.J.; Main, M.J.; Wise, A.; Brown, J.; Thompson, N.; Solari, R.; Lee, M.G.; Foord, S.M. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature, 1998, 393, 333-339.
16. Shindo, T.; Kurihara, Y.; Nishimatsu, H.; Moriyama, N.; Kakoki, M.; Wang, Y.; Imai, Y.; Ebihara, A.; Kuwaki, T.; Ju, K.H.; Minamino, N.; Kangawa, K.; Ishikawa, T.; Fukuda, M.; Akimoto, Y.; Kawakami, H.; Imai, T.; Morita, H.; Yazaki, Y.; Nagai, R.; Hirata, Y.; Kurihara, H. Vascular abnormalities and elevated blood pressure in mice lacking adrenomedullin gene. Circulation, 2001, 104, 1964-1971.
17. Caron, K.M.; Smithies, O. Extreme hydrops fetalis and cardiovascular abnormalities in mice lacking a functional Adrenomedullin gene. Proc. Natl. Acad. Sci. USA, 2001, 98, 615-619.
18. Rosenfeld, M.G.; Mermod, J.J.; Amara, S.G.; Swanson, L.W.; Sawchenko, P.E.; Rivier, J.; Vale, W.W.; Evans, R.M. Production of a novel neuropeptide encoded by the calcitonin gene via tissuespecific RNA processing. Nature, 1983, 304, 129-135.
19. Oh-hashi, Y.; Shindo, T.; Kurihara, Y.; Imai, T.; Wang, Y.; Morita, H.; Imai, Y.; Kayaba, Y.; Nishimatsu, H.; Suematsu, Y.; Hirata, Y.; Yazaki, Y.; Nagai, R.; Kuwaki, T.; Kurihara, H. Elevated sympathetic nervous activity in mice deficient in alphaCGRP. Circ. Res., 2001, 89, 983-990.
20. Toda, M.; Suzuki, T.; Hosono, K.; Hayashi, I.; Hashiba, S.; Onuma, Y.; Amano, H.; Kurihara, Y.; Kurihara, H.; Okamoto, H.; Hoka, S.; Majima, M. Neuronal system-dependent facilitation of tumor angiogenesis and tumor growth by calcitonin gene-related peptide. Proc. Nat. Acad. Sci. USA., 2008, 105, 13550-13555.
21. Toda, M.; Suzuki, T.; Hosono, K.; Kurihara, Y.; Kurihara, H.; Hayashi, I.; Kitasato, H.; Hoka, S.; Majima, M. Roles of calcitonin gene-related peptide in facilitation of wound healing and angiogenesis. Biomed. pharmacotherap. Biomed. pharmacotherap., 2008, 62, 352-359.
22. Shindo, T.; Kurihara, H.; Maemura, K.; Kurihara, Y.; Kuwaki, T.; Izumida, T.; Minamino, N.; Ju, K.H.; Morita, H.; Oh-hashi, Y.; Kumada, M.; Kangawa, K.; Nagai, R.; Yazaki, Y. Hypotension and resistance to lipopolysaccharide-induced shock in transgenic mice overexpressing adrenomedullin in their vasculature. Circulation, 2000, 101, 2309-2316.
23. Nishimatsu, H.; Hirata, Y.; Shindo, T.; Kurihara, H.; Kakoki, M.; Nagata, D.; Hayakawa, H.; Satonaka, H.; Sata, M.; Tojo, A.; Suzuki, E.; Kangawa, K.; Matsuo, H.; Kitamura, T.; Nagai, R. Role of endogenous adrenomedullin in the regulation of vascular tone and ischemic renal injury: studies on transgenic/knockout mice of adrenomedullin gene. Circ. Res., 2002, 90, 657-663.
24. Iimuro, S.; Shindo, T.; Moriyama, N.; Amaki, T.; Niu, P.; Takeda, N.; Iwata, H.; Zhang, Y.; Ebihara, A.; Nagai, R. Angiogenic effects of adrenomedullin in ischemia and tumor growth. Circ. Res., 2004, 95, 415-423.
25. Abe, M.; Sata, M.; Nishimatsu, H.; Nagata, D.; Suzuki, E.; Terauchi, Y.; Kadowaki, T.; Minamino, N.; Kangawa, K.; Matsuo, H.; Hirata, Y.; Nagai, R. Adrenomedullin augments collateral development in response to acute ischemia. Biochem. Biophys. Res. Communicat., 2003, 306, 10-15.
26. Miyashita, K.; Itoh, H.; Sawada, N.; Fukunaga, Y.; Sone, M.; Yamahara, K.; Yurugi-Kobayashi, T.; Park, K.; Nakao, K. Adrenomedullin provokes endothelial Akt activation and promotes vascular regeneration both in vitro and in vivo. FEBS Lett., 2003, 544, 86-92.
27. Iwase, T.; Nagaya, N.; Fujii, T.; Itoh, T.; Ishibashi-Ueda, H.; Yamagishi, M.; Miyatake, K.; Matsumoto, T.; Kitamura, S.; Kangawa, K. Adrenomedullin enhances angiogenic potency of bone marrow transplantation in a rat model of hindlimb ischemia. Circulation, 2005, 111, 356-362.
28. Ichikawa-Shindo, Y.; Sakurai, T.; Kamiyoshi, A.; Kawate, H.; Iinuma, N.; Yoshizawa, T.; Koyama, T.; Fukuchi, J.; Iimuro, S.; Moriyama, N.; Kawakami, H.; Murata, T.; Kangawa, K.; Nagai, R.; Shindo, T. The GPCR modulator protein RAMP2 is essential for angiogenesis and vascular integrity. J. Clin. Invest., 2008, 118, 29-39.
29. Abe, M.; Sata, M.; Suzuki, E.; Takeda, R.; Takahashi, M.; Nishimatsu, H.; Nagata, D.; Kangawa, K.; Matsuo, H.; Nagai, R.; Hirata, Y. Effects of adrenomedullin on acute ischaemia-induced collateral development and mobilization of bone-marrow-derived cells. Clinical Sci., 2006, 111, 381-387.
30. Martinez, A.; Vos, M.; Guedez, L.; Kaur, G.; Chen, Z.; Garayoa, M.; Pio, R.; Moody, T.; Stetler-Stevenson, W.G.; Kleinman, H.K.; Cuttitta, F. The effects of adrenomedullin overexpression in breast tumor cells. J. Natl. Cancer Inst., 2002, 94, 1226-1237.
31. Li, Z.; Takeuchi, S.; Otani, T.; Maruo, T. Implications of adrenomedullin expression in the invasion of squamous cell carcinoma of the uterine cervix. Int. J. Clin. Oncol., 2001, 6, 263-270.
32. Forneris, M.; Gottardo, L.; Albertin, G.; Malendowicz, L.K.; Nussdorfer, G.G. Expression and function of adrenomedullin and its receptors in Conn's adenoma cells. Int. J. Mol. Med., 2001, 8, 675-679.
33. Rocchi, P.; Boudouresque, F.; Zamora, A.J.; Muracciole, X.; Lechevallier, E.; Martin, P.M.; Ouafik, L. Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines. Cancer Res., 2001, 61, 1196-1206.
34. Hata, K.; Takebayashi, Y.; Akiba, S.; Fujiwaki, R.; Iida, K.; Nakayama, K.; Nakayama, S.; Fukumoto, M.; Miyazaki, K. Expression of the adrenomedullin gene in epithelial ovarian cancer. Mol. Hum. Reprod., 2000, 6, 867-872.
35. Kuwasako, K.; Cao, Y.N.; Nagoshi, Y.; Kitamura, K.; Eto, T. Adrenomedullin receptors: pharmacological features and possible pathophysiological roles. Peptides, 2004, 25, 2003-2012.
36. Parameswaran, N.; Spielman, W.S. RAMPs: The past, present and future. Trends Biochem. Sci., 2006, 31, 631-638.
37. Morfis, M.; Christopoulos, A.; Sexton, P.M. RAMPs: 5 years on, where to now? Trends Pharmacol. Sci., 2003, 24, 596-601.
38. Fritz-Six, K.L.; Dunworth, W.P.; Li, M.; Caron, K.M. Adrenomedullin signaling is necessary for murine lymphatic vascular development. J. Clin. Invest., 2008, 118, 40-50.
39. Kahn, M.L. Blood is thicker than lymph. J. Clin. Invest., 2008, 118, 23-26.
40. Tam, C.W.; Husmann, K.; Clark, N.C.; Clark, J.E.; Lazar, Z.; Ittner, L.M.; Gotz, J.; Douglas, G.; Grant, A.D.; Sugden, D.; Poston, L.; Poston, R.; McFadzean, I.; Marber, M.S.; Fischer, J.A.; Born, W.; Brain, S.D. Enhanced vascular responses to adrenomedullin in mice overexpressing receptor-activity-modifying protein 2. Circulat. Res., 2006, 98, 262-270.
41. Hojo, Y.; Ikeda, U.; Ohya, K.; Ichida, M.; Kario, K.; Takahashi, M.; Ikeda, M.; Minota, S.; Isumi, Y.; Minamino, N.; Ishimitsu, T.; Shimada, K. Interaction between monocytes and vascular endothelial cells induces adrenomedullin production. Atherosclerosis, 2001, 155, 381-387.
42. Imai, Y.; Shindo, T.; Maemura, K.; Sata, M.; Saito, Y.; Kurihara, Y.; Akishita, M.; Osuga, J.; Ishibashi, S.; Tobe, K.; Morita, H.; Ohhashi, Y.; Suzuki, T.; Maekawa, H.; Kangawa, K.; Minamino, N.; Yazaki, Y.; Nagai, R.; Kurihara, H. Resistance to neointimal hyperplasia and fatty streak formation in mice with adrenomedullin overexpression. Arterioscler. Thromb. Vasc. Biol., 2002, 22, 1310-1315.
43. Kawai, J.; Ando, K.; Tojo, A.; Shimosawa, T.; Takahashi, K.; Onozato, M.L.; Yamasaki, M.; Ogita, T.; Nakaoka, T.; Fujita, T. Endogenous adrenomedullin protects against vascular response to injury in mice. Circulation, 2004, 109, 1147-1153.
44. McKeown, C.M.; Edwards, V.; Phillips, M.J.; Harvey, P.R.; Petrunka, C.N.; Strasberg, S.M. Sinusoidal lining cell damage: the critical injury in cold preservation of liver allografts in the rat. Transplantation, 1988, 46, 178-191.
45. Caldwell-Kenkel, J.C.; Currin, R.T.; Tanaka, Y.; Thurman, R.G.; Lemasters, J.J. Reperfusion injury to endothelial cells following cold ischemic storage of rat livers. Hepatology, 1989, 10, 292-299.
46. Iinuma, N.; Sakurai, T.; Kamiyoshi, A.; Ichikawa-Shindo, Y.; Arai, T.; Yoshizawa, T.; Koyama, T.; Uetake, R.; Kawate, H.; Muto, S.; Tagawa, Y.; Miyagawa, S.; Shindo, T. Adrenomedullin in sinusoidal endothelial cells play protective roles against cold injury of liver. Peptides, 2010, 31, 865-871.
47. Arai, T.; Sakurai, T.; Kamiyoshi, A.; Ichikawa-Shindo, Y.; Iinuma, N.; Iesato, Y.; Koyama, T.; Yoshizawa, T.; Uetake, R.; Yamauchi, A.; Yang, L.; Kawate, H.; Ogawa, S.; Kobayashi, A.; Miyagawa, S.; Shindo, T. Induction of LYVE-1/stabilin-2-positive liver sinusoidal endothelial-like cells from embryoid bodies by modulation of adrenomedullin-RAMP2 signaling. Peptides, 2011, 32, 1855-1865.
48. Sexton, P.M.; Albiston, A.; Morfis, M.; Tilakaratne, N. Receptor activity modifying proteins. Cell Signal, 2001, 13, 73-83.
49. Dackor, R.; Fritz-Six, K.; Smithies, O.; Caron, K. Receptor activity-modifying proteins 2 and 3 have distinct physiological functions from embryogenesis to old age. J. Biol. Chem., 2007, 282, 18094-18099.
50. Barrick, C.J.; Lenhart, P.M.; Dackor, R.T.; Nagle, E.; Caron, K.M. Loss of receptor activity-modifying protein 3 exacerbates cardiac hypertrophy and transition to heart failure in a sex-dependent manner. J. Mol. Cell. Cardiol., 2012, 52, 165-174.
51. Watanabe, H.; Takahashi, E.; Kobayashi, M.; Goto, M.; Krust, A.; Chambon, P.; Iguchi, T. The estrogen-responsive adrenomedullin and receptor-modifying protein 3 gene identified by DNA microarray analysis are directly regulated by estrogen receptor. J. Mol. Endocrinol., 2006, 36, 81-89.
52. Ono, Y.; Okano, I.; Kojima, M.; Okada, K.; Kangawa, K. Decreased gene expression of adrenomedullin receptor in mouse lungs during sepsis. Biochem. Biophys. Res. Commun., 2000, 271, 197-202.
53. Bomberger, J.M.; Parameswaran, N.; Hall, C.S.; Aiyar, N.; Spielman, W.S. Novel function for receptor activity-modifying proteins (RAMPs) in post-endocytic receptor trafficking. J. Biol. Chem., 2005, 280, 9297-9307.
54. Tsujikawa, K.; Yayama, K.; Hayashi, T.; Matsushita, H.; Yamaguchi, T.; Shigeno, T.; Ogitani, Y.; Hirayama, M.; Kato, T.; Fukada, S.; Takatori, S.; Kawasaki, H.; Okamoto, H.; Ikawa, M.; Okabe, M.; Yamamoto, H. Hypertension and dysregulated proinflammatory cytokine production in receptor activitymodifying protein 1-deficient mice. Proc. Nat. Acad. Sci. USA., 2007, 104, 16702-16707.
55. Kamiyoshi, A.; Sakurai, T.; Ichikawa-Shindo, Y.; Fukuchi, J.; Kawate, H.; Muto, S.; Tagawa, Y.; Shindo, T. Endogenous alphaCGRP protects against concanavalin A-induced hepatitis in mice. Biochem. Biophys. Res. Communicat., 2006, 343, 152-158.
56. Kamiyoshi, A.; Sakurai, T.; Ichikawa-Shindo, Y.; Iinuma, N.; Kawate, H.; Yoshizawa, T.; Koyama, T.; Muto, S.; Shindo, T. Endogenous alpha-calcitonin gene-related peptide mitigates liver fibrosis in chronic hepatitis induced by repeated administration of concanavalin A. Liver international: official journal of the International Association for the Study of the Liver, 2009, 29, 642-649.
57. Sabharwal, R.; Zhang, Z.; Lu, Y.; Abboud, F.M.; Russo, A.F.; Chapleau, M.W. Receptor activity-modifying protein 1 increases baroreflex sensitivity and attenuates Angiotensin-induced hypertension. Hypertension, 2010, 55, 627-635.
58. Muff, R.; Buhlmann, N.; Fischer, J.A.; Born, W. An amylin receptor is revealed following co-transfection of a calcitonin receptor with receptor activity modifying proteins-1 or -3. Endocrinology, 1999, 140, 2924-2927.
59. Christopoulos, G.; Perry, K.J.; Morfis, M.; Tilakaratne, N.; Gao, Y.; Fraser, N.J.; Main, M.J.; Foord, S.M.; Sexton, P.M. Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product. Molecular pharmacology, 1999, 56, 235-242.
60. Sexton, P.M.; Morfis, M.; Tilakaratne, N.; Hay, D.L.; Udawela, M.; Christopoulos, G.; Christopoulos, A. Complexing receptor pharmacology: modulation of family B G protein-coupled receptor function by RAMPs. Annals of the New York Academy of Sciences, 2006, 1070, 90-104.